Philadelphia, PA. – The Biotechnology Industry Organization (BIO) announced its selection of New Jersey State Assemblywoman Pamela Lampitt (6th District) as a state Legislator of the Year for 2015. Assemblywoman Lampitt is the prime sponsor of A-2477, which authorizes the prescription and dispensing of biosimilar products in New Jersey. Assemblywoman Lampitt received this honor during the 2015 BIO International Convention.
“Assemblywoman Lampitt’s has worked hard to ensure the people of New Jersey have quality health care,” said BIO President and CEO Jim Greenwood. “We are pleased to name Assemblywoman Lampitt as a Legislators of the Year to recognize her leadership in working with fellow lawmakers to craft legislation that will ensure patients have choices when it comes to prescription medication, as well as ample information to help them make smart decisions.”
“BioNJ is proud to have nominated Assemblywoman Lampitt for this prestigious honor," said Debbie Hart, President and CEO, BioNJ. "We applaud Assemblywoman Lampitt for her continued support for finding cures for patients and thank her for her leadership in advancing the biosimilars legislation in New Jersey."
The 2015 BIO International Convention is the world’s largest biotechnology event, and will run through Thursday, June 18. Hosted by the Biotechnology Industry Organization, this year’s event, which is taking place in the Philadelphia Convention Center, is expected to attract more than 3,000 biotechnology companies and more than 15,000 attendees from 48 states and 65 countries.
“BioNJ is proud to have nominated Assemblywoman Lampitt for this prestigious honor," said Debbie Hart, President and CEO, BioNJ. "We applaud Assemblywoman Lampitt for her continued support for finding cures for patients and thank her for her leadership in advancing the biosimilars legislation in New Jersey."
The 2015 BIO International Convention is the world’s largest biotechnology event, and will run through Thursday, June 18. Hosted by the Biotechnology Industry Organization, this year’s event, which is taking place in the Philadelphia Convention Center, is expected to attract more than 3,000 biotechnology companies and more than 15,000 attendees from 48 states and 65 countries.
